Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMID 7860097)

Published in Hybridoma on October 01, 1994

Authors

P V Lemley1, P Amanatides, D C Wright

Author Affiliations

1: Toxinology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011.

Articles citing this

A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin. Infect Immun (2009) 1.68

Folding domains within the ricin toxin A subunit as targets of protective antibodies. Vaccine (2010) 1.60

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine (2007) 1.55

Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Emerg Infect Dis (2002) 1.51

Characterization of a novel high-affinity monoclonal immunoglobulin G antibody against the ricin B subunit. Infect Immun (2006) 1.50

Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication. Infect Immun (2006) 1.32

Immunity to ricin: fundamental insights into toxin-antibody interactions. Curr Top Microbiol Immunol (2012) 1.28

Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB). Vaccine (2011) 1.22

Introduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogen. Proteins (2011) 1.12

Monoclonal antibodies and toxins--a perspective on function and isotype. Toxins (Basel) (2012) 1.09

Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant α-helix in ricin toxin's enzymatic subunit. Toxicon (2012) 1.08

The need for continued development of ricin countermeasures. Adv Prev Med (2012) 1.08

Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized. PLoS One (2013) 1.06

Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA). Immunol Lett (2013) 1.04

Chimeric plantibody passively protects mice against aerosolized ricin challenge. Clin Vaccine Immunol (2014) 1.03

Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit. Vaccine (2011) 0.99

Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity. World J Biol Chem (2010) 0.99

Passive and active vaccination strategies to prevent ricin poisoning. Toxins (Basel) (2011) 0.98

Comparative efficacy of two leading candidate ricin toxin a subunit vaccines in mice. Clin Vaccine Immunol (2013) 0.96

Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro. J Immunol Methods (2013) 0.95

Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA. Vaccine (2010) 0.95

Sub-domains of ricin's B subunit as targets of toxin neutralizing and non-neutralizing monoclonal antibodies. PLoS One (2012) 0.94

Structure of RiVax: a recombinant ricin vaccine. Acta Crystallogr D Biol Crystallogr (2011) 0.93

A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine (2010) 0.92

Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents. Br J Pharmacol (2010) 0.89

Antibody-mediated inhibition of ricin toxin retrograde transport. MBio (2014) 0.89

Crystal structures of ricin toxin's enzymatic subunit (RTA) in complex with neutralizing and non-neutralizing single-chain antibodies. J Mol Biol (2014) 0.88

LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity. PLoS One (2013) 0.88

AB toxins: a paradigm switch from deadly to desirable. Toxins (Basel) (2010) 0.88

Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen. Hum Vaccin Immunother (2013) 0.88

Inhibitors of the cellular trafficking of ricin. Toxins (Basel) (2012) 0.87

Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin's Enzymatic Subunit Interfere with Intracellular Toxin Transport. Sci Rep (2016) 0.85

Mechanistic insights into the neutralization of cytotoxic abrin by the monoclonal antibody D6F10. PLoS One (2013) 0.82

Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin. J Biol Chem (2013) 0.82

Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies. Biomed Res Int (2012) 0.82

Progress and challenges associated with the development of ricin toxin subunit vaccines. Expert Rev Vaccines (2016) 0.78

Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit. Proteins (2016) 0.76

Recent advances in the development of vaccines against ricin. Hum Vaccin Immunother (2016) 0.76

Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies. MAbs (2016) 0.75

A monoclonal antibody to an abrin chimera recognizing a unique epitope on abrin A chain confers protection from abrin-induced lethality. Hum Vaccin Immunother (2015) 0.75

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59

The Walter Reed staging classification for HTLV-III/LAV infection. N Engl J Med (1986) 2.44

Acoustic neuromas: results of current surgical management. Neurosurgery (1997) 2.12

Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose. J Immunol Methods (1985) 1.93

Extreme lateral transcondylar approach: technical improvements and lessons learned. J Neurosurg (1994) 1.91

Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery (1995) 1.80

Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. JAMA (1985) 1.76

Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. J Infect Dis (1986) 1.73

Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission. JAMA (1985) 1.65

Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA (1987) 1.59

A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis (1999) 1.51

Posterior fossa meningiomas: surgical experience in 161 cases. Surg Neurol (2001) 1.45

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR Am J Roentgenol (1988) 1.41

Surgical treatment of basilar aneurysms. Neurosurgery (1979) 1.38

Endodermal cysts of the posterior fossa. Report of three cases and review of the literature. J Neurosurg (1998) 1.25

Translabyrinthine approach to skull base tumors with hearing preservation. Am J Otol (1993) 1.17

Surgical anatomy of the infratemporal fossa: the styloid diaphragm revisited. Neurosurgery (1998) 1.16

The effect of chronic food and water restriction on open-field behaviour and serum corticosterone levels in rats. Lab Anim (2000) 1.11

Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccharides. Antibiot Chemother (1971) (1985) 1.11

Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery (1996) 1.10

Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep (1980) 1.09

Variations of the extreme-lateral craniocervical approach: anatomical study and clinical analysis of 69 patients. J Neurosurg (1999) 1.07

Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J Neurosurg (1996) 1.06

Management and long-term outcome of adenoid cystic carcinoma with intracranial extension: a neurosurgical perspective. Neurosurgery (1996) 1.06

Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. Infect Immun (1994) 1.06

Vasospasm after cranial base tumor resection: pathogenesis, diagnosis, and therapy. Surg Neurol (1999) 1.05

Cranial base approaches to intracranial aneurysms in the subarachnoid space. Neurosurgery (1994) 1.04

Partial labyrinthectomy petrous apicectomy approach to neoplastic and vascular lesions of the petroclival area. Neurosurgery (1999) 1.02

The results of surgery for benign tumors of the cavernous sinus. Neurosurgery (1995) 0.99

Cranial chordomas: clinical presentation and results of operative and radiation therapy in twenty-six patients. Neurosurgery (1985) 0.99

Surgical excision of meningiomas involving the clivus: preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg (1994) 0.98

Petroclival and foramen magnum meningiomas: surgical approaches and pitfalls. J Neurooncol (1996) 0.93

Collaborative Behavioral Teratology Study: results. Neurobehav Toxicol Teratol (1986) 0.93

Fatal Yersinia enterocolitica sepsis after blood transfusion. Arch Pathol Lab Med (1985) 0.93

Persistent trigeminal artery: an anatomic study. Neurosurgery (1998) 0.93

Mice are actively immunized after passive monoclonal antibody prophylaxis and ricin toxin challenge. Immunology (1992) 0.91

Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg (1991) 0.91

Drug streaming during intra-arterial chemotherapy. J Neurosurg (1986) 0.91

Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies. J Neurosurg (1987) 0.90

The effect of 125I interstitial radiotherapy on blood-brain barrier function in normal canine brain. J Neurosurg (1987) 0.90

Bilateral microphthalmos with orbital cysts: MR findings. J Comput Assist Tomogr (1987) 0.89

Delayed c-fos proto-oncogene expression in the rat hippocampus induced by transient global cerebral ischemia: an in situ hybridization study. Brain Res (1989) 0.87

Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague-Dawley rat. J Cereb Blood Flow Metab (1988) 0.87

Chordomas and chondrosarcomas of the skull base: results and complications of surgical management. Neurosurg Focus (2001) 0.83

Generalized chronic dermatophytosis in patients with human immunodeficiency virus type I infection and CD4 depletion. Arch Dermatol (1991) 0.82

Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum (1994) 0.82

Proposed grading system to predict the extent of resection and outcomes for cranial base meningiomas. Neurosurgery (1999) 0.82

Cerebrospinal fluid rhinorrhea: depiction with MR cisternography in dogs. Radiology (1986) 0.80

Meningeal carcinomatosis in the VX2 rabbit tumor model: detection with Gd-DTPA-enhanced MR imaging. Radiology (1988) 0.80

Differentiating stimulus and storage hypotheses of state-dependent learning. Fed Proc (1974) 0.80

The petrolingual ligament: the anatomy and surgical exposure of the posterolateral landmark of the cavernous sinus. Acta Neurochir (Wien) (1998) 0.79

Surgical treatment of meningiomas involving the cavernous sinus: evolving ideas based on a ten year experience. Acta Neurochir Suppl (1996) 0.79

Memory, learning ability, and neuropathologic status of mice with systemic lupus erythematosus. Ann N Y Acad Sci (1997) 0.79

Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy. J Neurosurg (1990) 0.78

Cadmium absorption and tissue distribution in rats provided low concentrations of cadmium in food or drinking water. J Toxicol Environ Health (1982) 0.78

Near infrared spectrophotometry for the diagnosis of vasculogenic erectile dysfunction. Int J Impot Res (2000) 0.78

Safety and immunogenicity of multiple conventional immunizations administered during early HIV infection. J Acquir Immune Defic Syndr (1991) 0.78

An increase in extracellular glutamate is a sensitive method of detecting ischaemic neuronal damage during cranial base and cerebrovascular surgery. An in vivo microdialysis study. Acta Neurochir (Wien) (1998) 0.78

Postischemic glucose metabolism is modified in the hippocampal CA1 region depleted of excitatory input or pyramidal cells. J Cereb Blood Flow Metab (1990) 0.78

Differentiation of fetal pig endocrine cells after allografting into the thymus gland. Transplantation (1999) 0.77

Outcomes analysis in cranial base surgery - preliminary results. Acta Neurochir (Wien) (1995) 0.77

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas. Neurosurgery (1989) 0.77

Sequential MR studies of intracerebral hematomas in monkeys. AJNR Am J Neuroradiol (1986) 0.77

The best treatment for vestibular schwannoma (acoustic neuroma): microsurgery or radiosurgery? Am J Otol (1996) 0.77

A male genital tract-specific carbohydrate epitope on human CD52: implications for immunocontraception. Tissue Antigens (2002) 0.77

125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods. Int J Radiat Oncol Biol Phys (1985) 0.77

Pituitary carcinoma. Skull Base Surg (1994) 0.76

Lowering of blood glucose to nondiabetic levels in a hyperglycemic pig by allografting of fetal pig isletlike cell clusters. Transplantation (2001) 0.76

Protection against tetrodotoxin and saxitoxin intoxication by a cross-protective rabbit anti-tetrodotoxin antiserum. Toxicon (1991) 0.76

The effect of unilateral and bilateral removal of the entorhinal cortex on the glucose utilization in various hippocampal regions in the rat. Neurosci Lett (1988) 0.76

The case for aggressive resection. Clin Neurosurg (1999) 0.76

Binding of [3H]inositoltrisphosphate and [3H]phorbol 12,13-dibutyrate in rat hippocampus following transient global ischemia: a quantitative autoradiographic study. Neurosci Lett (1989) 0.76

Management of Zone III Missile Injuries Involving the Carotid Artery and Cranial Nerves. Skull Base Surg (2000) 0.75

A protocol for measuring ophthalmologic morbidity and recovery after cranial base surgery. Skull Base Surg (1994) 0.75

In situ drug delivery. Br J Cancer Suppl (1980) 0.75

The NCI-atlas of dose distributions for regular 125I brain implants. Radiother Oncol (1987) 0.75

Interpretation of behavioral teratology data. Neurobehav Toxicol Teratol (1986) 0.75

Surgical resection of cranial base meningiomas. Neurosurg Clin N Am (1994) 0.75

Effects of experimentally induced hyperlysinemia on maze learning in mice. Physiol Behav (1973) 0.75

Reversible sodium pentobarbital amnesia in one trial discrimination learning. Pharmacol Biochem Behav (1975) 0.75

In vitro tarnish measurements on fixed prosthodontic alloys. J Prosthet Dent (1982) 0.75

Copper and silver corrosion activity in crown and bridge alloys. J Dent Res (1981) 0.75

Enzyme-linked immunosorbent assay quantification of cytokine concentrations in human meningiomas. Neurosurgery (1996) 0.75

Synthesis of methyl alpha- and beta-D-xylopyranoside-5-18O. Carbohydr Res (1976) 0.75

Vein graft replacement of the middle cerebral artery after unsuccessful embolectomy: case report. Neurosurgery (1993) 0.75

State dependent learning produced by post trial intrathoracic administration of sodium pentobarbital. Psychopharmacologia (1973) 0.75

Retrograde state dependent learning. Science (1973) 0.75

Correlation of corrosion behavior and cytotoxicity in Au-Cu-Ag ternary alloys. J Biomed Mater Res (1982) 0.75

Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease. J Am Acad Dermatol (1985) 0.75

Attenuation provided by four different audiometric earphone systems. Ear Hear (1990) 0.75

Naloxone eliminates passive avoidance retention deficits produced by pretest exposure to novelty in rats. Behav Neural Biol (1991) 0.75

Fetal pig endocrine cells develop when allografted into the thymus gland. Transplant Proc (1999) 0.75

AIDS. Case for diagnosis series, 1987. Mil Med (1987) 0.75

MR imaging of primary tumors of trigeminal nerve and Meckel's cave. AJR Am J Roentgenol (1988) 0.75

Similarity responding by monkeys in a matching to sample task. J Comp Physiol Psychol (1968) 0.75